# Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients

> **NCT01351480** · PHASE3 · COMPLETED · sponsor: **Arthritis & Rheumatic Disease Specialties Research** · enrollment: 34 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** abatacept

## Key facts

- **NCT ID:** NCT01351480
- **Lead sponsor:** Arthritis & Rheumatic Disease Specialties Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2014-01
- **Final completion:** 2014-04
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01351480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01351480, "Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01351480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*